Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 817

1.

Correction: Widespread white matter microstructural abnormalities in bipolar disorder: evidence from mega- and meta-analyses across 3033 individuals.

Favre P, Pauling M, Stout J, Hozer F, Sarrazin S, Abé C, Alda M, Alloza C, Alonso-Lana S, Andreassen OA, Baune BT, Benedetti F, Busatto GF, Canales-Rodríguez EJ, Caseras X, Chaim-Avancini TM, Ching CRK, Dannlowski U, Deppe M, Eyler LT, Fatjo-Vilas M, Foley SF, Grotegerd D, Hajek T, Haukvik UK, Howells FM, Jahanshad N, Kugel H, Lagerberg TV, Lawrie SM, Linke JO, McIntosh A, Melloni EMT, Mitchell PB, Polosan M, Pomarol-Clotet E, Repple J, Roberts G, Roos A, Rosa PGP, Salvador R, Sarró S, Schofield PR, Serpa MH, Sim K, Stein DJ, Sussmann JE, Temmingh HS, Thompson PM, Verdolini N, Vieta E, Wessa M, Whalley HC, Zanetti MV, Leboyer M, Mangin JF, Henry C, Duchesnay E, Houenou J; ENIGMA Bipolar Disorder Working Group.

Neuropsychopharmacology. 2019 Sep 16. doi: 10.1038/s41386-019-0521-6. [Epub ahead of print]

PMID:
31527792
2.

The influence of the working alliance on the treatment and outcomes of patients with bipolar disorder: A systematic review.

Andrade-González N, Hernández-Gómez A, Álvarez-Sesmero S, Gutiérrez-Rojas L, Vieta E, Reinares M, Lahera G.

J Affect Disord. 2019 Sep 3;260:263-271. doi: 10.1016/j.jad.2019.09.014. [Epub ahead of print] Review.

PMID:
31521862
3.

Risk factors for posttraumatic stress disorder: an umbrella review of systematic reviews and meta-analyses.

Tortella-Feliu M, Fullana MA, Pérez-Vigil A, Torres X, Chamorro J, Littarelli SA, Solanes A, Ramella-Cravaro V, Vilar A, González-Parra JA, Andero R, Reichenberg PA, Mataix-Cols PD, Vieta E, Fusar-Poli P, Ioannidis PJPA, Stein PMB, Radua J, de la Cruz LF.

Neurosci Biobehav Rev. 2019 Sep 11. pii: S0149-7634(19)30601-3. doi: 10.1016/j.neubiorev.2019.09.013. [Epub ahead of print] Review.

PMID:
31520677
4.

Affective cognition in bipolar disorder: A systematic review by the ISBD targeting cognition task force.

Miskowiak KW, Seeberg I, Kjaerstad HL, Burdick KE, Martinez-Aran A, Bonnin CM, Bowie CR, Carvalho AF, Gallagher P, Hasler G, Lafer B, López-Jaramillo C, Sumiyoshi T, McIntyre RS, Schaffer A, Porter RJ, Purdon S, Torres IJ, Yatham LN, Young AH, Kessing LV, Van Rheenen TE, Vieta E.

Bipolar Disord. 2019 Sep 6. doi: 10.1111/bdi.12834. [Epub ahead of print]

PMID:
31491048
5.

Effectiveness of a Pharmacogenetic Tool at Improving Treatment Efficacy in Major Depressive Disorder: A Meta-Analysis of Three Clinical Studies.

Vilches S, Tuson M, Vieta E, Álvarez E, Espadaler J.

Pharmaceutics. 2019 Sep 2;11(9). pii: E453. doi: 10.3390/pharmaceutics11090453.

6.

An International Society of Bipolar Disorders task force report: Precursors and prodromes of bipolar disorder.

Faedda GL, Baldessarini RJ, Marangoni C, Bechdolf A, Berk M, Birmaher B, Conus P, DelBello MP, Duffy AC, Hillegers MHJ, Pfennig A, Post RM, Preisig M, Ratheesh A, Salvatore P, Tohen M, Vázquez GH, Vieta E, Yatham LN, Youngstrom EA, Van Meter A, Correll CU.

Bipolar Disord. 2019 Sep 3. doi: 10.1111/bdi.12831. [Epub ahead of print]

PMID:
31479581
7.

Psychotic disorders versus other psychiatric diagnoses in consultation-liaison psychiatry: 10 years of a single-center experience.

Sánchez-González R, Monteagudo-Gimeno E, Rodríguez-Urrutia A, Vieta E, Pérez-Solá V, Herranz-Villanueva S, Pintor-Pérez L.

Actas Esp Psiquiatr. 2019 Jul;47(4):149-57. Epub 2019 Jul 1.

8.

Widespread white matter microstructural abnormalities in bipolar disorder: evidence from mega- and meta-analyses across 3033 individuals.

Favre P, Pauling M, Stout J, Hozer F, Sarrazin S, Abé C, Alda M, Alloza C, Alonso-Lana S, Andreassen OA, Baune BT, Benedetti F, Busatto GF, Canales-Rodríguez EJ, Caseras X, Chaim-Avancini TM, Ching CRK, Dannlowski U, Deppe M, Eyler LT, Fatjo-Vilas M, Foley SF, Grotegerd D, Hajek T, Haukvik UK, Howells FM, Jahanshad N, Kugel H, Lagerberg TV, Lawrie SM, Linke JO, McIntosh A, Melloni EMT, Mitchell PB, Polosan M, Pomarol-Clotet E, Repple J, Roberts G, Roos A, Rosa PGP, Salvador R, Sarró S, Schofield PR, Serpa MH, Sim K, Stein DJ, Sussmann JE, Temmingh HS, Thompson PM, Verdolini N, Vieta E, Wessa M, Whalley HC, Zanetti MV, Leboyer M, Mangin JF, Henry C, Duchesnay E, Houenou J; ENIGMA Bipolar Disorder Working Group.

Neuropsychopharmacology. 2019 Aug 21. doi: 10.1038/s41386-019-0485-6. [Epub ahead of print] Erratum in: Neuropsychopharmacology. 2019 Sep 16;:.

PMID:
31434102
9.

Progression of the functional deficit in a group of patients with bipolar disorder: a cluster analysis based on longitudinal data.

López-Villarreal A, Sánchez-Morla EM, Jiménez-López E, Martínez-Vizcaíno V, Aparicio AI, Mateo-Sotos J, Rodriguez-Jimenez R, Vieta E, Santos JL.

Eur Arch Psychiatry Clin Neurosci. 2019 Aug 17. doi: 10.1007/s00406-019-01050-9. [Epub ahead of print]

PMID:
31422453
10.

The role of different patterns of psychomotor symptoms in major depressive episode: Pooled analysis of the BRIDGE and BRIDGE-II-MIX cohorts.

Barbuti M, Mainardi C, Pacchiarotti I, Verdolini N, Maccariello G, Angst J, Azorin JM, Bowden CL, Mosolov S, Young AH, Vieta E, Perugi G.

Bipolar Disord. 2019 Aug 10. doi: 10.1111/bdi.12816. [Epub ahead of print]

PMID:
31400256
11.

Beyond evidence-based treatment of bipolar disorder: Rational pragmatic approaches to management.

Post RM, Yatham LN, Vieta E, Berk M, Nierenberg AA.

Bipolar Disord. 2019 Jul 25. doi: 10.1111/bdi.12813. [Epub ahead of print]

PMID:
31343802
12.

Bipolar II Disorder: Frequent, Valid, and Reliable.

Vieta E.

Can J Psychiatry. 2019 Aug;64(8):541-543. doi: 10.1177/0706743719855040. No abstract available.

PMID:
31340672
13.

Lifetime Psychotic Symptoms, Subthreshold Depression and Cognitive Impairment as Barriers to Functional Recovery in Patients with Bipolar Disorder.

Bonnín CM, Jiménez E, Solé B, Torrent C, Radua J, Reinares M, Grande I, Ruíz V, Sánchez-Moreno J, Martínez-Arán A, Vieta E.

J Clin Med. 2019 Jul 18;8(7). pii: E1046. doi: 10.3390/jcm8071046.

14.

Adverse outcomes during pregnancy and major congenital malformations in infants of patients with bipolar and schizoaffective disorders treated with antiepileptic drugs: A systematic review.

Giménez A, Pacchiarotti I, Gil J, Murru A, Gomes SP, Pinzón JE, Anmella G, Gómez-Ramiro M, Verdolini N, Valentí M, Goikolea JM, Vieta E.

Psychiatr Pol. 2019 Apr 30;53(2):223-244. doi: 10.12740/PP/105906. Epub 2019 Apr 30. English, Polish.

15.

Completed suicide in bipolar disorder patients: A cohort study after first hospitalization.

Plans L, Nieto E, Benabarre A, Vieta E.

J Affect Disord. 2019 Oct 1;257:340-344. doi: 10.1016/j.jad.2019.07.048. Epub 2019 Jul 5.

PMID:
31302523
16.

Neurocognitive endophenotypes in schizophrenia and bipolar disorder: A systematic review of longitudinal family studies.

Luperdi SC, Tabarés-Seisdedos R, Livianos L, Vieta E, Cuesta MJ, Balanzá-Martínez V.

Schizophr Res. 2019 Aug;210:21-29. doi: 10.1016/j.schres.2019.06.014. Epub 2019 Jul 1. Review.

PMID:
31272906
17.

A 12-month prospective study on the time to hospitalization and clinical management of a cohort of bipolar type I and schizoaffective bipolar patients.

Murru A, Verdolini N, Anmella G, Pacchiarotti I, Samalin L, Aedo A, Undurraga J, Goikolea JM, Amann BL, Carvalho AF, Vieta E.

Eur Psychiatry. 2019 Sep;61:1-8. doi: 10.1016/j.eurpsy.2019.06.001. Epub 2019 Jun 28.

PMID:
31255957
18.

Novel antipsychotics specificity profile: A clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone.

Corponi F, Fabbri C, Bitter I, Montgomery S, Vieta E, Kasper S, Pallanti S, Serretti A.

Eur Neuropsychopharmacol. 2019 Sep;29(9):971-985. doi: 10.1016/j.euroneuro.2019.06.008. Epub 2019 Jun 27. Review.

PMID:
31255396
19.

Effects of electroconvulsive therapy in the systemic inflammatory balance of patients with severe mental disorder.

Bioque M, Mac-Dowell KS, Meseguer A, Macau E, Valero R, Vieta E, Leza JC, Bernardo M.

Psychiatry Clin Neurosci. 2019 Jun 28. doi: 10.1111/pcn.12906. [Epub ahead of print]

PMID:
31250493
20.

Patterns of response to antidepressants in major depressive disorder: Drug resistance or worsening of depression are associated with a bipolar diathesis.

Perugi G, Pacchiarotti I, Mainardi C, Verdolini N, Menculini G, Barbuti M, Angst J, Azorin JM, Bowden CL, Mosolov S, Young AH, Vieta E; BRIDGE-II-MIX Study Group.

Eur Neuropsychopharmacol. 2019 Jul;29(7):825-834. doi: 10.1016/j.euroneuro.2019.06.001. Epub 2019 Jun 18.

PMID:
31227264
21.

Food craving and consumption evolution in patients starting treatment with clozapine.

Garriga M, Mallorquí A, Serrano L, Ríos J, Salamero M, Parellada E, Gómez-Ramiro M, Oliveira C, Amoretti S, Vieta E, Bernardo M, García-Rizo C.

Psychopharmacology (Berl). 2019 Jun 13. doi: 10.1007/s00213-019-05291-3. [Epub ahead of print]

PMID:
31197435
22.

Association of childhood trauma and genetic variability of CRH-BP and FKBP5 genes with suicidal behavior in bipolar patients.

Segura AG, Mitjans M, Jiménez E, Fatjó-Vilas M, Ruiz V, Saiz PA, García-Portilla MP, González-Blanco L, Bobes J, Vieta E, Benabarre A, Arias B.

J Affect Disord. 2019 Aug 1;255:15-22. doi: 10.1016/j.jad.2019.05.014. Epub 2019 May 8.

PMID:
31195252
23.

Relationships between recurrence and polarity in major depressive disorders: Pooled analysis of the BRIDGE and BRIDGE-II-MIX cohorts.

Barbuti M, Mazzarini L, Vieta E, Azorin JM, Angst J, Bowden CL, Mosolov S, Young AH, Perugi G; BRIDGE-II-Mix Study Group.

J Affect Disord. 2019 Sep 1;256:250-258. doi: 10.1016/j.jad.2019.06.005. Epub 2019 Jun 4.

PMID:
31195243
24.

Association of Anorexia Nervosa With Risk of Cancer: A Systematic Review and Meta-analysis.

Catalá-López F, Forés-Martos J, Driver JA, Page MJ, Hutton B, Ridao M, Alonso-Arroyo A, Macías Saint-Gerons D, Gènova-Maleras R, Valderas JM, Vieta E, Valencia A, Tabarés-Seisdedos R.

JAMA Netw Open. 2019 Jun 5;2(6):e195313. doi: 10.1001/jamanetworkopen.2019.5313.

25.

Risk and protective factors for anxiety and obsessive-compulsive disorders: an umbrella review of systematic reviews and meta-analyses.

Fullana MA, Tortella-Feliu M, Fernández de la Cruz L, Chamorro J, Pérez-Vigil A, Ioannidis JPA, Solanes A, Guardiola M, Almodóvar C, Miranda-Olivos R, Ramella-Cravaro V, Vilar A, Reichenberg A, Mataix-Cols D, Vieta E, Fusar-Poli P, Fatjó-Vilas M, Radua J.

Psychol Med. 2019 Jun 7:1-16. doi: 10.1017/S0033291719001247. [Epub ahead of print]

PMID:
31172897
26.

Pharmacotherapy for the peripartum management of bipolar disorder.

Belzeaux R, Sanguinetti C, Murru A, Verdolini N, Pacchiarotti I, Hidalgo-Mazzei D, Cohen L, Anmella G, Barbuti M, Vieta E, Llorca PM, Samalin L.

Expert Opin Pharmacother. 2019 Jun 10:1-11. doi: 10.1080/14656566.2019.1626826. [Epub ahead of print]

PMID:
31159601
27.

The role of overlapping excitatory symptoms in major depression: are they relevant for the diagnosis of mixed state?

Brancati GE, Vieta E, Azorin JM, Angst J, Bowden CL, Mosolov S, Young AH, Perugi G; BRIDGE–II–Mix Study Group.

J Psychiatr Res. 2019 Aug;115:151-157. doi: 10.1016/j.jpsychires.2019.05.014. Epub 2019 May 14.

PMID:
31132693
28.

Auditory hallucinations in first-episode psychosis: A voxel-based morphometry study.

Escarti MJ, Garcia-Marti G, Sanz-Requena R, Marti-Bonmatí L, Cabrera B, Vieta E, Lobo A, Castro-Fornieles J, González-Pinto A, Cortizo R, Pina-Camacho L, Parellada M, Bernardo M, Sanjuan J; PEPs Group.

Schizophr Res. 2019 Jul;209:148-155. doi: 10.1016/j.schres.2019.05.001. Epub 2019 May 18.

PMID:
31113747
29.

What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD/IGSLI Task Force on treatment with lithium.

Nolen WA, Licht RW, Young AH, Malhi GS, Tohen M, Vieta E, Kupka RW, Zarate C, Nielsen RE, Baldessarini RJ, Severus E; ISBD/IGSLI Task Force on the treatment with lithium.

Bipolar Disord. 2019 Aug;21(5):394-409. doi: 10.1111/bdi.12805. Epub 2019 Jun 20. Review.

PMID:
31112628
30.

Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study.

Popova V, Daly EJ, Trivedi M, Cooper K, Lane R, Lim P, Mazzucco C, Hough D, Thase ME, Shelton RC, Molero P, Vieta E, Bajbouj M, Manji H, Drevets WC, Singh JB.

Am J Psychiatry. 2019 Jun 1;176(6):428-438. doi: 10.1176/appi.ajp.2019.19020172. Epub 2019 May 21. Erratum in: Am J Psychiatry. 2019 Aug 1;176(8):669.

PMID:
31109201
31.

One decade of the first episodes project (PEPs): Advancing towards a precision psychiatry.

Bernardo M, Cabrera B, Arango C, Bioque M, Castro-Fornieles J, Cuesta MJ, Lafuente A, Parellada M, Saiz-Ruiz J, Vieta E.

Rev Psiquiatr Salud Ment. 2019 Jul - Sep;12(3):135-140. doi: 10.1016/j.rpsm.2019.03.001. Epub 2019 May 16. English, Spanish. No abstract available.

PMID:
31103407
32.

Intravenous vortioxetine to accelerate onset of effect in major depressive disorder: a 2-week, randomized, double-blind, placebo-controlled study.

Vieta E, Florea I, Schmidt SN, Areberg J, Ettrup A.

Int Clin Psychopharmacol. 2019 Jul;34(4):153-160. doi: 10.1097/YIC.0000000000000271.

33.

Improving Functioning, Quality of Life, and Well-being in Patients With Bipolar Disorder.

Bonnín CDM, Reinares M, Martínez-Arán A, Jiménez E, Sánchez-Moreno J, Solé B, Montejo L, Vieta E.

Int J Neuropsychopharmacol. 2019 Aug 1;22(8):467-477. doi: 10.1093/ijnp/pyz018.

34.

Antipsychotic-induced weight gain and birth weight in psychosis: A fetal programming model.

Garriga M, Fernandez-Egea E, Mallorqui A, Serrano L, Oliveira C, Parellada E, Kirkpatrick B, Vieta E, Bernardo M, Garcia-Rizo C.

J Psychiatr Res. 2019 Aug;115:29-35. doi: 10.1016/j.jpsychires.2019.05.004. Epub 2019 May 4.

PMID:
31085376
35.

The Global Aging & Geriatric Experiments in Bipolar Disorder Database (GAGE-BD) project: Understanding older-age bipolar disorder by combining multiple datasets.

Sajatovic M, Eyler LT, Rej S, Almeida OP, Blumberg HP, Forester BP, Forlenza OV, Gildengers A, Mulsant BH, Strejilevich S, Tsai S, Vieta E, Young RC, Dols A.

Bipolar Disord. 2019 May 13. doi: 10.1111/bdi.12795. [Epub ahead of print]

PMID:
31081573
36.

Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis.

Bioque M, Mas S, Costanzo MC, Cabrera B, Lobo A, González-Pinto A, Rodriguez-Toscano E, Corripio I, Vieta E, Baeza I, Ibáñez Á, Fraile MG, Cuesta MJ, Mezquida G, Lafuente A, Bernardo M; PEPs GROUP.

Eur Neuropsychopharmacol. 2019 Jun;29(6):786-794. doi: 10.1016/j.euroneuro.2019.04.005. Epub 2019 May 7.

PMID:
31076188
37.

Functional remediation improves bipolar disorder functioning with no effects on brain-derived neurotrophic factor levels.

Bonnin CDM, Valls E, Rosa AR, Reinares M, Jimenez E, Solé B, Montejo L, Meseguer A, Pacchiarotti I, Colom F, Martinez-Aran A, Tomioka Y, Vieta E, Torrent C.

Eur Neuropsychopharmacol. 2019 Jun;29(6):701-710. doi: 10.1016/j.euroneuro.2019.04.002. Epub 2019 May 7.

PMID:
31076186
38.

Genome-wide association study identifies 30 loci associated with bipolar disorder.

Stahl EA, Breen G, Forstner AJ, McQuillin A, Ripke S, Trubetskoy V, Mattheisen M, Wang Y, Coleman JRI, Gaspar HA, de Leeuw CA, Steinberg S, Pavlides JMW, Trzaskowski M, Byrne EM, Pers TH, Holmans PA, Richards AL, Abbott L, Agerbo E, Akil H, Albani D, Alliey-Rodriguez N, Als TD, Anjorin A, Antilla V, Awasthi S, Badner JA, Bækvad-Hansen M, Barchas JD, Bass N, Bauer M, Belliveau R, Bergen SE, Pedersen CB, Bøen E, Boks MP, Boocock J, Budde M, Bunney W, Burmeister M, Bybjerg-Grauholm J, Byerley W, Casas M, Cerrato F, Cervantes P, Chambert K, Charney AW, Chen D, Churchhouse C, Clarke TK, Coryell W, Craig DW, Cruceanu C, Curtis D, Czerski PM, Dale AM, de Jong S, Degenhardt F, Del-Favero J, DePaulo JR, Djurovic S, Dobbyn AL, Dumont A, Elvsåshagen T, Escott-Price V, Fan CC, Fischer SB, Flickinger M, Foroud TM, Forty L, Frank J, Fraser C, Freimer NB, Frisén L, Gade K, Gage D, Garnham J, Giambartolomei C, Pedersen MG, Goldstein J, Gordon SD, Gordon-Smith K, Green EK, Green MJ, Greenwood TA, Grove J, Guan W, Guzman-Parra J, Hamshere ML, Hautzinger M, Heilbronner U, Herms S, Hipolito M, Hoffmann P, Holland D, Huckins L, Jamain S, Johnson JS, Juréus A, Kandaswamy R, Karlsson R, Kennedy JL, Kittel-Schneider S, Knowles JA, Kogevinas M, Koller AC, Kupka R, Lavebratt C, Lawrence J, Lawson WB, Leber M, Lee PH, Levy SE, Li JZ, Liu C, Lucae S, Maaser A, MacIntyre DJ, Mahon PB, Maier W, Martinsson L, McCarroll S, McGuffin P, McInnis MG, McKay JD, Medeiros H, Medland SE, Meng F, Milani L, Montgomery GW, Morris DW, Mühleisen TW, Mullins N, Nguyen H, Nievergelt CM, Adolfsson AN, Nwulia EA, O'Donovan C, Loohuis LMO, Ori APS, Oruc L, Ösby U, Perlis RH, Perry A, Pfennig A, Potash JB, Purcell SM, Regeer EJ, Reif A, Reinbold CS, Rice JP, Rivas F, Rivera M, Roussos P, Ruderfer DM, Ryu E, Sánchez-Mora C, Schatzberg AF, Scheftner WA, Schork NJ, Shannon Weickert C, Shehktman T, Shilling PD, Sigurdsson E, Slaney C, Smeland OB, Sobell JL, Søholm Hansen C, Spijker AT, St Clair D, Steffens M, Strauss JS, Streit F, Strohmaier J, Szelinger S, Thompson RC, Thorgeirsson TE, Treutlein J, Vedder H, Wang W, Watson SJ, Weickert TW, Witt SH, Xi S, Xu W, Young AH, Zandi P, Zhang P, Zöllner S; eQTLGen Consortium; BIOS Consortium, Adolfsson R, Agartz I, Alda M, Backlund L, Baune BT, Bellivier F, Berrettini WH, Biernacka JM, Blackwood DHR, Boehnke M, Børglum AD, Corvin A, Craddock N, Daly MJ, Dannlowski U, Esko T, Etain B, Frye M, Fullerton JM, Gershon ES, Gill M, Goes F, Grigoroiu-Serbanescu M, Hauser J, Hougaard DM, Hultman CM, Jones I, Jones LA, Kahn RS, Kirov G, Landén M, Leboyer M, Lewis CM, Li QS, Lissowska J, Martin NG, Mayoral F, McElroy SL, McIntosh AM, McMahon FJ, Melle I, Metspalu A, Mitchell PB, Morken G, Mors O, Mortensen PB, Müller-Myhsok B, Myers RM, Neale BM, Nimgaonkar V, Nordentoft M, Nöthen MM, O'Donovan MC, Oedegaard KJ, Owen MJ, Paciga SA, Pato C, Pato MT, Posthuma D, Ramos-Quiroga JA, Ribasés M, Rietschel M, Rouleau GA, Schalling M, Schofield PR, Schulze TG, Serretti A, Smoller JW, Stefansson H, Stefansson K, Stordal E, Sullivan PF, Turecki G, Vaaler AE, Vieta E, Vincent JB, Werge T, Nurnberger JI, Wray NR, Di Florio A, Edenberg HJ, Cichon S, Ophoff RA, Scott LJ, Andreassen OA, Kelsoe J, Sklar P; Bipolar Disorder Working Group of the Psychiatric Genomics Consortium.

Nat Genet. 2019 May;51(5):793-803. doi: 10.1038/s41588-019-0397-8. Epub 2019 May 1.

PMID:
31043756
39.

Cognitive Reserve Assessment Scale in Health (CRASH): Its Validity and Reliability.

Amoretti S, Cabrera B, Torrent C, Bonnín CDM, Mezquida G, Garriga M, Jiménez E, Martínez-Arán A, Solé B, Reinares M, Varo C, Penadés R, Grande I, Salagre E, Parellada E, Bioque M, Garcia-Rizo C, Meseguer A, Anmella G, Rosa AR, Contreras F, Safont G, Vieta E, Bernardo M.

J Clin Med. 2019 Apr 28;8(5). pii: E586. doi: 10.3390/jcm8050586.

40.

Obstetric complications in bipolar disorder: The role of mental health disorders in the risk of caesarean section.

Solé E, Torres A, Roca A, Hernández AS, Roda E, Sureda B, Martin-Santos R, Vieta E, Garcia-Esteve L.

J Affect Disord. 2019 Jun 1;252:458-463. doi: 10.1016/j.jad.2019.04.017. Epub 2019 Apr 8.

PMID:
31004826
41.

Association between solar insolation and a history of suicide attempts in bipolar I disorder.

Bauer M, Glenn T, Alda M, Andreassen OA, Angelopoulos E, Ardau R, Ayhan Y, Baethge C, Bauer R, Baune BT, Becerra-Palars C, Bellivier F, Belmaker RH, Berk M, Bersudsky Y, Bicakci Ş, Birabwa-Oketcho H, Bjella TD, Cabrera J, Wo Cheung EY, Del Zompo M, Dodd S, Donix M, Etain B, Fagiolini A, Fountoulakis KN, Frye MA, Gonzalez-Pinto A, Gottlieb JF, Grof P, Harima H, Henry C, Isometsä ET, Janno S, Kapczinski F, Kardell M, Khaldi S, Kliwicki S, König B, Kot TL, Krogh R, Kunz M, Lafer B, Landén M, Larsen ER, Lewitzka U, Licht RW, Lopez-Jaramillo C, MacQueen G, Manchia M, Marsh W, Martinez-Cengotitabengoa M, Melle I, Meza-Urzúa F, Ming MY, Monteith S, Morken G, Mosca E, Mozzhegorov AA, Munoz R, Mythri SV, Nacef F, Nadella RK, Nery FG, Nielsen RE, O'Donovan C, Omrani A, Osher Y, Sørensen HØ, Ouali U, Ruiz YP, Pilhatsch M, Pinna M, da Ponte FDR, Quiroz D, Ramesar R, Rasgon N, Reddy MS, Reif A, Ritter P, Rybakowski JK, Sagduyu K, Raghuraman BS, Scippa ÂM, Severus E, Simhandl C, Stackhouse PW Jr, Stein DJ, Strejilevich S, Subramaniam M, Sulaiman AH, Suominen K, Tagata H, Tatebayashi Y, Tondo L, Torrent C, Vaaler AE, Vares E, Veeh J, Vieta E, Viswanath B, Yoldi-Negrete M, Zetin M, Zgueb Y, Whybrow PC.

J Psychiatr Res. 2019 Jun;113:1-9. doi: 10.1016/j.jpsychires.2019.03.001. Epub 2019 Mar 8.

PMID:
30878786
42.

Prevalence and correlates of major depressive disorder, bipolar disorder and schizophrenia among nursing home residents without dementia: systematic review and meta-analysis.

Fornaro M, Solmi M, Stubbs B, Veronese N, Monaco F, Novello S, Fusco A, Anastasia A, De Berardis D, Carvalho AF, de Bartolomeis A, Vieta E.

Br J Psychiatry. 2019 Mar 13:1-10. doi: 10.1192/bjp.2019.5. [Epub ahead of print]

PMID:
30864533
43.

47 Sustained Functional Recovery and Symptom Remission After Maintenance Treatment with Aripiprazole Once-Monthly for Patients with Bipolar I Disorder.

Vieta E, Baker RA, Madera JJ, Zhang P, Such P, Chen M, Calabrese J.

CNS Spectr. 2019 Feb;24(1):201-202. doi: 10.1017/S1092852919000403.

PMID:
30859975
44.

Longitudinal brain functional changes between mania and euthymia in bipolar disorder.

Alonso-Lana S, Moro N, McKenna PJ, Sarró S, Romaguera A, Monté GC, Maristany T, Goikolea JM, Vieta E, Salvador R, Pomarol-Clotet E.

Bipolar Disord. 2019 Aug;21(5):449-457. doi: 10.1111/bdi.12767. Epub 2019 Apr 25.

PMID:
30848539
45.

The implications of hypersomnia in the context of major depression: Results from a large, international, observational study.

Murru A, Guiso G, Barbuti M, Anmella G, Verdolini N, Samalin L, Azorin JM, Angst JJ, Bowden CL, Mosolov S, Young AH, Popovic D, Valdes M, Perugi G, Vieta E, Pacchiarotti I; BRIDGE-II-Mix Study Group.

Eur Neuropsychopharmacol. 2019 Apr;29(4):471-481. doi: 10.1016/j.euroneuro.2019.02.011. Epub 2019 Mar 4.

PMID:
30846287
46.

Predominant polarity in bipolar disorder patients: The COPE bipolar sample.

Sentissi O, Popovic D, Moeglin C, Stukalin YB, Mosheva M, Vieta E, Serretti A, Souery D.

J Affect Disord. 2019 May 1;250:43-50. doi: 10.1016/j.jad.2019.02.053. Epub 2019 Feb 20.

PMID:
30826493
47.

A systematic review on sleep alterations anticipating the onset of bipolar disorder.

Pancheri C, Verdolini N, Pacchiarotti I, Samalin L, Delle Chiaie R, Biondi M, Carvalho AF, Valdes M, Ritter P, Vieta E, Murru A.

Eur Psychiatry. 2019 May;58:45-53. doi: 10.1016/j.eurpsy.2019.02.003. Epub 2019 Feb 25.

PMID:
30818134
48.

Treatment-resistant and Multi-therapy resistant criteria for bipolar depression: consensus definition - CORRIGENDUM.

Hidalgo-Mazzei D, Berk M, Cipriani A, Cleare AJ, Di Florio A, Dietch D, Geddes JR, Goodwin GM, Grunze H, Hayes JF, Jones I, Kasper S, Macritchie K, Hamish McAllister-Williams R, Morriss R, Nayrouz S, Pappa S, Soares JC, Smith DJ, Suppes T, Talbot P, Vieta E, Watson S, Yatham LN, Young AH, Stokes PRA.

Br J Psychiatry. 2019 May;214(5):309. doi: 10.1192/bjp.2019.36. Epub 2019 Feb 28. No abstract available.

PMID:
30816078
49.

High BDNF serum levels are associated to good cognitive functioning in bipolar disorder.

Mora E, Portella MJ, Piñol-Ripoll G, López R, Cuadras D, Forcada I, Teres M, Vieta E, Mur M.

Eur Psychiatry. 2019 Aug;60:97-107. doi: 10.1016/j.eurpsy.2019.02.006. Epub 2019 Feb 23.

PMID:
30808582
50.

Sultans of Swing: A Reappraisal of the Intertwined Association Between Affective Lability and Mood Reactivity in a Post Hoc Analysis of the BRIDGE-II-MIX Study.

Verdolini N, Menculini G, Perugi G, Murru A, Samalin L, Angst J, Azorin JM, Bowden CL, Mosolov S, Young AH, Barbuti M, Popovic D, Vieta E, Pacchiarotti I; BRIDGE-II-MIX Study Group.

J Clin Psychiatry. 2019 Feb 19;80(2). pii: 17m12082. doi: 10.4088/JCP.17m12082.

PMID:
30786180

Supplemental Content

Support Center